Sheba Pediatric CAR-T Program for Leukemia (ALL & CLL)
Qu'est-ce qui est inclus dans ce forfait
Procédures Médicales
- Analyse sanguine biochimique
- Numération globulaire complète
- Consultation avec un hématologue
- Analyse approfondie du sang
- Сonsultation avec un oncohématologue
- Diagnostic complet de la leucémie
- Thérapie CAR T
- Service infirmier 24h/24
- 3 repas par jour élaborés par un nutritionniste
- Consultation avec un oncologue
- Consultation avec un hématologue
- Consultation avec un immunologiste
- Consultation avec un hématologue pédiatrique
- Consultation avec un pédiatre
- Formule sanguine complète avec marqueurs de cancer et protéinogramme
- Échocardiographie
- Échocardiographie Doppler couleur
- Radiographie pulmonaire
- IRM de la tête
- Test anti-VIH
- Test anti-HBC
- Test anti-VHCAb
Durée
- 21 jours à l'hôpital
Hébergement
Hospitalisation
Transport
Transfert aéroport-hôtel-aéroport
Informations complémentaires
Sheba Pediatric CAR-T Program for Leukemia (ALL & CLL)
At Sheba Medical Center, children and young patients with leukemia have access to one of the most advanced and trusted CAR-T therapy programs in the world. The program specializes in treating acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) including relapsed or treatment-resistant cases using highly personalized immunotherapy.
A Personalized Treatment Designed for Each Patient
CAR-T therapy uses the patient’s own immune system to recognize and destroy leukemia cells. This approach is especially important for patients who have not responded to standard treatments.
At Sheba, the entire process is performed on-site, ensuring speed and optimal quality:
Apheresis – collection of immune (T) cells
Cell Engineering – genetic modification at Sheba’s Advanced Biotherapy Center
Infusion – reintroduction of modified cells to target leukemia
Because no steps are outsourced, treatment can begin quickly and is typically completed within ~10 days. CAR-T acts as a “living therapy,” continuing to work in the body over time.
Expert Care in a Supportive Environment
Patients are treated by leading hemato-oncology specialists, under the supervision of Prof. Amos Toren, within dedicated CAR-T units.
The program provides:
Specialized pediatric and young adult CAR-T care with 24/7 monitoring
A multidisciplinary team (hematology, oncology, immunology)
A supportive, patient- and family-centered environment
Full international patient services, including travel and care coordination
Proven Outcomes and Global Leadership
Sheba is a global leader in CAR-T therapy, with strong clinical outcomes:
~90% remission in pediatric patients
~80% in young adults (up to 23 years)
~70% in adults
The program is experienced in treating complex and high-risk leukemia cases, offering options when other treatments are limited.
Comprehensive Evaluation and Ongoing Support
Each patient undergoes a full diagnostic work-up, including:
advanced imaging, bone marrow biopsy, genetic and molecular testing, as well as cardiac and pulmonary evaluation.
Care is provided in English, Russian, and Arabic, ensuring clear communication and continuous support for international families.
A Place Patients and Families Can Trust
By combining advanced science, rapid access to treatment, and compassionate care, Sheba offers one of the most trusted CAR-T programs for leukemia—focused on achieving remission and helping patients return to a healthy, active life.
Assistance Bookimed 24/7
- Coordinateur médical personnel
- Organisation de voyage médical — réservation des tickets de vol et des chambres d'hôtel à des prix réduits pour les partenaires
- Prise en charge du patient lors d'un voyage médical
Prix du programme
Ce qui n'est PAS inclus dans ce forfait
Médecin
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Où en sommes-nous ?
À propos de la clinique
Le centre médical Sheba est l'un des meilleurs hôpitaux d'Israël et du monde. Le magazine Newsweek International a classé l' hôpital Sheba parmi les 10 meilleurs hôpitaux du monde en 2020. L'hôpital couvre 1 990 spécialités et plus de 1 500 000 patients du monde entier se rendent à l'hôpital Sheba pour se faire soigner chaque année.
Paiement et récompenses
Vous ne payez pas pour nos services
Vous effectuez votre paiement directement à la clinique ou sur leur compte bancaire officiel.
Certaines cliniques peuvent exiger un acompte dans le cadre de leur politique.
Étalez vos paiements avec des options de versements.
Gagnez des récompenses en parrainant vos amis sur Bookimed.